Lv7
4660 积分 2024-06-28 加入
Targeted protein degradation: from mechanisms to clinic
11天前
已完结
REGULATION OF MUSCLE MASS BY MYOSTATIN
17天前
已关闭
Discovery of Novel N-Hydroxy-1,2,4-oxadiazole-5-formamides as ASM Direct Inhibitors for the Treatment of Atherosclerosis
22天前
已完结
Discovery of a Novel ASM Direct Inhibitor with a 1,5-Diphenyl-pyrazole Scaffold and Its Antidepressant Mechanism of Action
22天前
已完结
Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trial
28天前
已完结
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
1个月前
已完结
Bone Mineral Density in Sclerosteosis; Affected Individuals and Gene Carriers
1个月前
已关闭
Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
1个月前
已完结
Single‐dose, placebo‐controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
1个月前
已完结
Sclerostin: from bench to bedside
1个月前
已完结
皖公网安备34019202002308
